The brush-shaped signboard of Kousetsuken
21:10 JST, December 30, 2023
A historic calligraphy supply store called Kousetsuken had a wooden signboard in the shape of a brush, passed down for nearly a century, which has now been stolen. The shop, located in Nakagyo-ku, Kyoto City, was established in the late Edo period and became a popular haunt for literary figures such as Junichiro Tanizaki and Mushakoji Saneatsu. The local police are treating it as a theft and are conducting an investigation.
The signboard was noticed as missing at around 6:30 p.m. on Tuesday. A plastic box, believed to have been used as a step, was left nearby. Terumichi Nagaoka, the 65-year-old fifth-generation owner of the store, reported the incident to the police on the same day.
The signboard has been popular among customers for many years, with some people even taking commemorative photos holding newly purchased brushes alongside it. It serves as part of the logo printed on the store’s paper bags. Weighing around 3 kilograms, the signboard was usually hung in front of the store at opening and brought inside after closing.
In July, there was also a case of a wooden signboard being stolen at Baiyoushoin, a Buddhist scripture publishing house established in the early Edo period, located about 40 meters to the east.
Top Articles in Society
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
15 Measles Patients Confirmed in Tokyo in Past 6 Days; 1 May Have Come into Contact with Many in Shibuya
-
Bus Carrying 40 Passengers Catches Fire on Chuo Expressway; All Evacuate Safely
-
Ibaraki Pref.’s 1st Foreign Bus Driver Hired in Tsukuba
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

